Late effects and quality of life of childhood cancer survivors: Part 2. Impact of radiotherapy
- 342 Downloads
To examine the late effects and health-related quality of life of childhood cancer survivors (CCS) after radiotherapy (RT), we performed a cross-sectional survey using self-rating questionnaires. The subjects were divided into 3 groups: CCS treated with or without RT, and a general population matched for age, gender, residential area, and work status. The numbers in each group were 113, 72, and 1,000, respectively. The median ages of CCS at diagnosis and the time of the survey were 8 and 22 years, respectively. The mean final heights of males and females were significantly lower in CCS with RT than in the other 2 groups. Risk factors for a short stature were total body irradiation (TBI) [odds ratio (OR) 17.8, p < 0.001], spinal irradiation (OR 8.31, p = 0.033), and an age younger than 10 years at diagnosis. Late effects were observed in 68% of CCS with RT compared with 36% of CCS without RT. Multivariate analysis revealed that TBI was significantly associated with endocrine dysfunction (OR 12.3), skull and spinal irradiation with cognitive dysfunction (OR 16.1 and 11.5, respectively), and spinal irradiation with a short stature (OR 14.1), respectively. Physical dysfunction, psychological stress, and problems of social adaptation were observed in >50% of CCS with RT.
KeywordsRadiotherapy Radiation Late effects Childhood cancer survivors Quality of life
The institutions that provided patient data and recruited CCS to the survey are listed in Table 1. This study was supported by research grants from the Japanese Ministry of Health, Labour and Welfare (Grant No. 18-14: “Study of quality of life and prognosis in childhood cancer survivors and establishment of a long-term follow-up system”).
Conflict of interest statement
The authors declare no financial interests.
- 2.Hawkins MM, Lancashire ER, Winter DL, Frobisher C, Reulen RC, Taylor AJ, et al. The British Childhood Cancer Survivor Study: objectives, methods, population structure, response rates and initial descriptive information. Pediatr Blood Cancer. 2008;50(5):1018–25. doi: 10.1002/pbc.21335.CrossRefPubMedGoogle Scholar
- 3.Geenen MM, Cardous-Ubbink MC, Kremer LC, van den Bos C, van der Pal HJ, Heinen RC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007;297(24):2705–15.Google Scholar
- 5.Ishida Y, Honda M, Ozono S, Okamura J, Asami K, Maeda N, et al. Late effects and quality of life of childhood cancer survivors: Part 1 Impact of the stem cell transplantation. Int J Hematol. 2010. doi: 10.1007/s12185-010-0584-y.
- 11.Ishiguro H, Yasuda Y, Tomita Y, Shinagawa T, Shimizu T, Morimoto T, et al. Long-term follow-up of thyroid function in patients who received bone marrow transplantation during childhood and adolescence. J Clin Endocrinol Metab. 2004;89(12):5981–6.Google Scholar
- 12.Ishida Y, Honda M, Kamibeppu K, Ozono S, Iwai T, Kakee N, et al. Cross-sectional survey on the late effects and QOL of childhood cancer survivors, Part 1. J Jpn Pediatr Soc. 2010;114(4):665–75.Google Scholar
- 13.Gurney JG, Ness KK, Stovall M, Wolden S, Punyko JA, Neglia JP, et al. Final height and body mass index among adult survivors of childhood brain cancer: childhood cancer survivor study. J Clin Endocrinol Metab. 2003;88(10):4731–9.Google Scholar
- 18.Chemaitilly W, Boulad F, Sklar C. Endocrine complications of childhood hematopoietic stem-cell transplantation. In: Kline R, editor. Pediatric hematopoietic stem cell transplantation. New York: Informa Healthcare USA; 2006. p. 287–398.Google Scholar
- 19.Rutter MM, Rose SR. Long-term endocrine sequelae of childhood cancer. Curr Opin Pediatr. 2007;19(4):480–7. doi: 10.1097/MOP.0b013e3282058b56-00008480-200708000-00017[pii].CrossRefPubMedGoogle Scholar
- 20.Sanders JE. Endocrine complications of high-dose therapy with stem cell transplantation. Pediatr Transplant. 2004;8(Suppl 5):39–50.Google Scholar
- 22.Brownstein CM, Mertens AC, Mitby PA, Stovall M, Qin J, Heller G, et al. Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study. J Clin Endocrinol Metab. 2004;89(9):4422–7.Google Scholar
- 23.Larson DL, Kroll S, Jaffe N, Serure A, Goepfert H. Long-term effects of radiotherapy in childhood and adolescence. Am J Surg. 1990;160(4):348–51.Google Scholar
- 25.Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2001;93(8):618–29.Google Scholar